Eikonoklastes Therapeutics jobs and careers
Cincinnati, OH, United States
About Eikonoklastes Therapeutics
Eikonoklastes is advancing a new generation of tissue factor (TF) immunotherapies – therapeutics designed to target the cell surface receptor now known to be prevalent on key components of the tumor microenvironment.
Founded in 2019 by Bruce Halpryn and Samuel Lee.
- Founded
- 2019
- Employees
- 1 to 10
- Total funding
- $6M
- Headquarters
- Cincinnati
Leadership
The top of Eikonoklastes Therapeutics's org chart, with how many people report into each leader.
Bruce Halpryn
Co-Founder & CEO
6 reports
Samuel Lee, MD, MBA
Co-Founder, President, and Chief Business Officer
2 reports
Vishal Agrawal
VP, CMC
Samuel Lee
Co-Founder & Chief Business Officer
Hernan Picard
Chief Medical Officer
Board
Tom Finn
Director
Kenneth Morand
Director
Neel Patel
Director
Meyer Frucher
Board Member
Seward Rutkove
Scientific Advisor
Michael O’Beirne
Scientific Advisor
Jobs at Eikonoklastes Therapeutics
No open positions right now. Explore more companies on TheJobsMap.